High-yield points
- VP: first-line. In a trial of first shunts, 61% were failure-free at 1 year and 47% at 2 years, mostly failing from obstruction and infection . Abdominal risks: pseudocyst (put back in the abdomen means more infection, moved elsewhere means more revisions) , and bowel perforation, mostly early .
- Anterior vs posterior entry: no significant difference in shunt failure or complications in an HCRN randomized trial (HR 1.35 for posterior, p = 0.06) . A later prospective HCRN cohort found posterior entry independently associated with failure .
- VPl: second-line in older children. The main risk is pleural effusion: 24% needing relocation under age 10 vs 11% over 10 , and 16% pooled . Pneumothorax 3.1% . Favored over VA when the peritoneum isn't usable after age 10 .
- VA: the most common alternative distal site, and used in younger children . Similar survival to VPl once age and etiology are accounted for . Needs lengthening with growth .
- VA-specific risks: thrombosis and emboli , pulmonary hypertension , and shunt nephritis. Remove the atrial catheter within 3 months of a nephritis diagnosis (OR 22.4 for poor outcome with delay) .
- LP: communicating hydrocephalus only, mainly for pseudotumor cerebri and selected slit-ventricle cases . Tonsillar herniation on imaging in about 70%, symptomatic in <5%, so get MRI surveillance . Horizontal-vertical valves may lower this risk .
Landmark papers
- Pediatric valve design trial (Drake et al., Neurosurgery 1998): a randomized trial of 344 children receiving their first shunt. Only 61% were free of shunt failure at 1 year and 47% at 2 years .
- HCRN entry-site trial (Whitehead et al., J Neurosurg Pediatr 2022): a randomized trial of anterior vs posterior entry. There was no significant difference in shunt failure or complications (HR 1.35 for posterior, p = 0.06) .
Ventriculoperitoneal (VP) shunts
The VP shunt is the default first shunt in children. The peritoneum absorbs CSF well, a long peritoneal catheter can be left to allow for growth, and the procedure is familiar to every pediatric neurosurgeon. Its main drawback is durability, a problem shared by shunts in general. In a randomized valve trial of 344 children receiving their first shunt, only 61% were free of shunt failure at 1 year and 47% at 2 years. Failures came mostly from obstruction (31%) and infection (8%), and valve design made no difference . The choice of entry site does not appear to matter. In an HCRN randomized trial of 453 children (median age 1.3 months) receiving their first VP shunt, time to shunt failure did not differ between anterior and posterior entry. There was a non-significant trend toward more failures with posterior entry (HR 1.35, 95% CI 0.98–1.85, p = 0.06). Operative time, number of catheter passes and catheter position were also similar, as were complications, including CSF leak, infection, seizures, new epilepsy and hemorrhage . A later prospective HCRN cohort of 3,686 children receiving a first shunt (2018–2024) came to a different conclusion. Posterior entry was independently associated with shunt failure, along with age under 6 months, tumor or posthemorrhagic hydrocephalus of prematurity, gastrostomy and two or more complex chronic conditions . The randomized trial is the stronger design, but the two results together suggest that anterior entry is at least as good and may be better. Distal problems are specific to the abdomen. Abdominal pseudocysts are usually treated by externalizing the shunt, and HCRN data show a trade-off in where to put the new distal catheter. Putting it back in the peritoneum led to more later infections (26% vs 7%), and moving it to a non-peritoneal site led to more non-infectious revisions (42% vs 23%). Shunt surgery within the 12 weeks before the pseudocyst independently predicted failure after treatment (HR 1.8) . Bowel perforation with anal extrusion of the catheter is rare but serious. It most often occurs in the first weeks after surgery, and 35% of reported cases had infectious complications . When the abdomen becomes hostile, the usual reasons for moving the distal catheter elsewhere are prior shunt infection, multiple abdominal operations, poor peritoneal absorption, pseudocyst and obesity .
Ventriculopleural (VPl) shunts
The pleural space is the usual second-line terminus in older children and adolescents. It is technically about as easy as a VP shunt, and in a series of 170 children (mean age 14 years) its complication rates were similar to those of VP shunts. 57% of these children needed no revision during a mean 57 months of follow-up, and infection occurred in 4.2% of procedures . The defining risk is pleural effusion, because the pleura's ability to absorb CSF is limited. In that series, 24% of children under 10 years developed an effusion that required moving the distal catheter out of the pleural space, compared with 11% of older children. Effusions were more common without an antisiphon device . A meta-analysis of 543 patients found revision in 54%, pleural effusion in 16%, infection in 7% and obstruction in 13%, with no shunt-related deaths . Pneumothorax is a VPl-specific risk, occurring in 3.1% in an HCRN comparison with VA shunts vs 0% for VA . In a single-institution series, VPl shunt survival was 76% at 1 year and 46% at 7 years . When the peritoneum cannot be used in a child over 10, all else being equal, the Children's Hospital Los Angeles group favors the pleura over the atrium .
Ventriculoatrial (VA) shunts
The VA shunt is the most common alternative when the peritoneum cannot be used, and it is used at younger ages than VPl shunts . In an HCRN study of 416 children, VA shunts were placed at a median age of 6.1 years vs 12.4 years for VPl shunts, and more often for hydrocephalus from intraventricular hemorrhage of prematurity. Cumulative revisions at 24 months were higher with VA shunts (48.6% vs 38.9%), and survival was shortest for VA shunts in children under 6. After adjusting for age and etiology, however, shunt type did not predict time to failure, and overall complications were similar (6.0% vs 9.2%) . VA shunts can be durable salvage options. In 52 children converted from a failing VP shunt, 1-year survival was 95.4% after conversion vs 68.0% for the preceding VP shunt periods . Their disadvantages are that the short atrial catheter must be lengthened as the child grows, and that their complications are vascular, cardiac and renal. In a long-term pediatric series, 52.2% of VA revisions were for dysfunction and 22.9% were elective lengthenings. That series also reported reversible tricuspid regurgitation from a catheter placed too deep, and one case of shunt nephritis . Shunt-associated thrombosis can be asymptomatic for long periods or life-threatening, and its true prevalence is uncertain . Chronic pulmonary emboli with pulmonary hypertension are a reported late complication . Shunt nephritis is an immune-complex glomerulonephritis, reported on average 5.8 years after insertion. Renal outcome is better the sooner the atrial catheter is removed: waiting 3 months or longer after diagnosis was associated with poor outcome (OR 22.4) . VA shunts therefore need long-term cardiopulmonary and renal follow-up .
Lumboperitoneal (LP) shunts
The LP shunt avoids the brain entirely. It works only in communicating hydrocephalus, so it suits pseudotumor cerebri (idiopathic intracranial hypertension), CSF fistula, and selected children with slit ventricles. In a Toronto series of 143 children, the better of the two LP designs had survival similar to VP shunts, with a 50% probability of remaining free of malfunction at 5 years. The percutaneous design migrated in 19%, and 28% of all patients were eventually converted to ventricular shunts . The major risk is acquired tonsillar herniation (acquired Chiari malformation). In the same Toronto cohort, it was found on CT in 70% of patients imaged and on MRI in 12 of 17 asymptomatic patients (71%). Fewer than 5% needed treatment, and one death was attributed to unsuspected herniation, so MRI surveillance is recommended . More recent experience is more favorable. One series converted children with slit ventricles to LP shunts after a successful lumbar drain trial confirmed communication, and used horizontal-vertical valves. Among patients with before-and-after imaging, none developed an acquired Chiari malformation, and no patient had acute deterioration from shunt malfunction . That series also lists the reasons surgeons traditionally hesitate to use LP shunts: overdrainage, difficulty tapping or revising the shunt, and progressive tonsillar herniation .
Related topics
- Shunt Failure: durability and modes of failure.
- Shunt Infections: risk, treatment and prevention.
- Programmable vs Nonprogrammable Shunt Valves: valve choice.
- Shunt Overdrainage and Slit Ventricle Syndrome: slit ventricles and LP shunts.
- Endoscopic Third Ventriculostomy (ETV): the alternative to shunting.
- Intraventricular Hemorrhage of Prematurity and Posthemorrhagic Hydrocephalus: posthemorrhagic hydrocephalus in preterm infants.
- Ventriculoperitoneal Shunt Insertion: step-by-step insertion.
- Ventriculoatrial Shunt Insertion: atrial shunting.
- Ventriculopleural Shunt Insertion: pleural shunting.
References
- Drake JM, Kestle JR, Milner R, et al. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 1998;43(2):294–303. doi:10.1097/00006123-199808000-00068. PMID 9696082. verified
- Whitehead WE, Riva-Cambrin J, Wellons JC, et al. Anterior versus posterior entry site for ventriculoperitoneal shunt insertion: a randomized controlled trial by the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr 2022;29(3):257–267. doi:10.3171/2021.9.PEDS21391. PMID 34798600. verified
- Ravindra VM, Jensen H, Riva-Cambrin J, et al. Comparison of outcomes in the management of abdominal pseudocyst in children with shunted hydrocephalus: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2023;32(3):312–323. doi:10.3171/2023.4.PEDS23129. PMID 37327184. verified
- Adel K, Fayçal A, Toufik B, et al. Bowel perforation and anal ventriculoperitoneal shunt migration: a systematic review. J Taibah Univ Med Sci 2024;19(2):263–269. doi:10.1016/j.jtumed.2023.12.002. PMID 38234714. verified
- Christian EA, Quezada JJ, Melamed EF, et al. Ventriculopleural shunts in a pediatric population: a review of 170 consecutive patients. J Neurosurg Pediatr 2021;28(4):450–457. doi:10.3171/2021.3.PEDS2176. PMID 34388722. verified
- Brenner LBO, Porto S, Andreão FF, et al. Are ventriculopleural shunts the second option for treating hydrocephalus? A meta-analysis of 543 patients. Clin Neurol Neurosurg 2024;244:108396. doi:10.1016/j.clineuro.2024.108396. PMID 38981168. verified
- Ravindra VM, Riva-Cambrin J, Jensen H, et al. Comparing ventriculoatrial and ventriculopleural shunts in pediatric hydrocephalus: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2024;34(4):305–314. doi:10.3171/2024.5.PEDS2469. PMID 38968629. verified
- Oyon DE, Behbahani M, Sharma S, et al. Ventriculopleural shunt outcomes for pediatric hydrocephalus: a single-institution experience. Childs Nerv Syst 2023;39(8):2105–2113. doi:10.1007/s00381-023-05928-x. PMID 37055486. verified
- Wu D, Guan Z, Xiao L, et al. Thrombosis associated with ventriculoatrial shunts. Neurosurg Rev 2022;45(2):1111–1122. doi:10.1007/s10143-021-01656-5. PMID 34647222. verified
- Erdoğan O, Şahin B, Şahin Y, et al. Ventriculoatrial shunting for recurrent ventriculoperitoneal shunt failure in pediatric hydrocephalus: a viable alternative with improved outcomes. Neurosurg Rev 2026;49(1). doi:10.1007/s10143-026-04511-7. PMID 42803841. verified
- Gmeiner M, Wagner H, van Ouwerkerk WJR, et al. Long-term outcomes in ventriculoatrial shunt surgery in patients with pediatric hydrocephalus: retrospective single-center study. World Neurosurg 2020;138:e112–e118. doi:10.1016/j.wneu.2020.02.035. PMID 32061956. verified
- Otero-Fernández P, Negreira-Caamaño M, Moreno-Flores A, et al. Pulmonary arterial hypertension due to ventriculoatrial shunts: a case report and literature review. Neurochirurgie 2022;68(6):684–687. doi:10.1016/j.neuchi.2022.03.002. PMID 35461815. verified
- Ajlan B, Maghrabi Y, Mokhtar G, et al. Timing of ventriculoatrial shunt removal on renal function recovery of patients with shunt nephritis: case report and systematic review. Clin Neurol Neurosurg 2022;218:107279. doi:10.1016/j.clineuro.2022.107279. PMID 35594721. verified
- Chumas PD, Kulkarni AV, Drake JM, et al. Lumboperitoneal shunting: a retrospective study in the pediatric population. Neurosurgery 1993;32(3):376–383. doi:10.1227/00006123-199303000-00007. PMID 8455762. verified
- Chumas PD, Armstrong DC, Drake JM, et al. Tonsillar herniation: the rule rather than the exception after lumboperitoneal shunting in the pediatric population. J Neurosurg 1993;78(4):568–573. doi:10.3171/jns.1993.78.4.0568. PMID 8450330. verified
- Marupudi NI, Harris C, Pavri T, et al. The role of lumboperitoneal shunts in managing chronic hydrocephalus with slit ventricles. J Neurosurg Pediatr 2018;22(6):632–637. doi:10.3171/2018.6.PEDS17642. PMID 30239284. verified
- Ravindra VM, Kestle JRW, Jensen H, et al. Cerebrospinal fluid shunt failure in children is associated with medical complexity and shunt position, not shunt technology: a multicenter prospective study from the Hydrocephalus Clinical Research Network. J Pediatr 2026;300:115308. doi:10.1016/j.jpeds.2026.115308. PMID 42716243. verified
Verification (2026-10-23): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract. Full texts were not reviewed. Reference 12 is a single case report with a literature review.